(European Society for Medical Oncology) The TAT 2019 Honorary Award for cancer drug development has been given to Dr Geoffrey Shapiro, Professor of Medicine at Harvard Medical School and Institute Physician at the Dana-Farber Cancer Institute, for his leadership in developmental therapeutics, particularly in solid tumours. The award will be presented during the International Congress on Targeted Anticancer Therapies (TAT) 2019, to be held in Paris, France, 25-27 February.
from EurekAlert! - Social and Behavioral Science http://bit.ly/2Mtl9k6
No comments:
Post a Comment